Commercial Expansion Appointment of a Vice President of Sales signals a focused effort to scale commercialization. A strategic relationship with Merit Medical Systems offers a ready distribution channel and hospital-network access to accelerate Surfacer adoption.

Vascular Occlusion Need The Surfacer Inside-Out Access Catheter System targets central venous access in patients with challenging or occluded venous anatomy. This creates opportunities to engage interventional teams and procurement within hospitals facing difficult access cases.

Clinical Progress Ongoing SAVE-US pivotal study provides clinical validation and a pathway to stronger value propositions with health systems. Positive trial momentum can support reimbursement discussions and wider clinical adoption.

Funding & Partners The company operates in early revenue and modest funding territory, suggesting potential sales acceleration through licensing, co development, or distribution partnerships with larger medtech players to scale manufacturing and reach.

Differentiated Technology A novel approach to central venous access positions Surfacer as a differentiator in a competitive space, enabling targeted conversations with hospitals, surgeons, and vascular access specialists about adopting a new standard of care.